L

📈 Stocks

[L @AustroBloom]

@RJCcapital Ich würde gerne deine Meinung zu $NUAI hören und wie du die Zukunft des Unternehmens siehst.

[L @AustroBloom]

@aleabitoreddit Ich würde gerne deine Meinung zu $NUAI hören und wie du die Zukunft des Unternehmens siehst.

[L @AustroBloom]

@napoleon21st No, the going concern issue has not been mitigated.

[L @AustroBloom]

$DARE Investors:

Big day tomorrow!
CEO Sabrina Martucci Johnson presents at #BIO2026.

June 23, 3:30 PM PDT (Theater 4)
Key focus areas for Tuesday:

• Commercial roll-out of Flora Sync LF5™
• Pipeline updates on DARE-HPV
• Multi-million $ non-dilutive funding strateg

[L @AustroBloom]

@ChairmansLedger Love $NUAI - hope 11$ soon

[L @AustroBloom]

Despite internal governance changes, $SIVE is fueling a massive rally driven by pure AI momentum.
Sales pipeline skyrocketed 77% to a staggering $799M.
Keys to the boom: GlobalFoundries AI laser partnership & an $8.2M defense/civil satellite order from https://t.co/3Exd3vE9tR

[L @AustroBloom]

@MktMavPro Techno raves

[L @AustroBloom]

$alrib

Key catalysts to watch:

ROSIE commercialization for photonics & quantum applications

More MBE orders linked to quantum dot lasers and AI data centers

Potential new customers as global quantum investment accelerates

[L @AustroBloom]

@Nordine2404 IBM
GlobalFoundries
Atom Computing
D-Wave Quantum
Infleqtion
PsiQuantum
Quantinuum
Rigetti Computing
Diraq

[L @AustroBloom]

$alrib $Riber:
Annual General Meeting of June 17, 2026: 
#RIBER confirms the execution of its technology roadmap and accelerates with ROSIE https://t.co/UazmPepjxn

[L @AustroBloom]

@aleabitoreddit News on $NUAI?

[L @AustroBloom]

@aleabitoreddit Buy the dip?

[L @AustroBloom]

@aleabitoreddit @SMike1271547 Any news on $alrib or $sive?

[L @AustroBloom]

@Sofigoodboy Bought the dip

[L @AustroBloom]

@Sofigoodboy But why?

[L @AustroBloom]

@aleabitoreddit @Mellokhai Any news on $alrib ?

[L @AustroBloom]

@aleabitoreddit What’s your view on $NUAI going forward after this recent surge?

[L @AustroBloom]

Fresh analysis points out that $VKTX’s recent pullback is a strong entry window and the market agrees!

Stock is surging nearly 10% today, breaking back above $35.

Superior weight-loss data vs peers gives it a clear tech edge ahead of Q3 Phase 3 trials & maintenance data.

[L @AustroBloom]

@DollarCostAvg $nuai + $sive

[L @AustroBloom]

@retail_mourinho $nuai + $sive

[L @AustroBloom]

@aleabitoreddit What’s your view on $NUAI going forward after this recent surge?

[L @AustroBloom]

Fresh market analysis today points out that $VKTX recent 8% pullback is a strong entry window.

With superior weight-loss data (14.7% loss for weekly injection / 12.2% oral) vs Eli Lilly & Novo Nordisk, the tech edge is clear ahead of Phase 3 trials this year.